Jun 12, 2019
Preston Klassen, MD Chief Medical Officer, Arena Pharmaceuticals talks about the challenges of treating Inflammatory Bowel Diseases (IBD) and Arena's developmental therapies for ulcerative colitis and Crohn's disease. We also talk about the development of a treatment for related gastrointestinal pain with a non-opioid alternative.
#Arena #Ulcerativecolitis
#GI #IBD #crohns
@ArenaPharm